Could Gilead Stock Get A Boost From Inhaled Remdesivir?

Gilead has indicated that it would be starting clinical trials for an inhaled version of Remdesivir shortly. While the wide-spectrum anti-viral drug is currently given intravenously for severe cases of Covid-19 in the hospital, the new delivery method could enable treatment at earlier stages of...